About Us

Who We Are

Pharmabinoid is a European cannabinoid supplier and development partner for companies that want to work with cannabinoids responsibly, transparently and at commercial scale. We support brands, formulators, manufacturers, laboratories and research-focused teams that need reliable cannabinoid ingredients, product knowledge and practical guidance before bringing a product to market.

Our work sits between cannabinoid science, production, quality control and market access. That means we do not only supply cannabinoids; we help customers understand which ingredient, format, documentation and compliance route makes sense for the product they want to create. Whether a project starts with CBD, CBG, CBN, CBC, HHC alternatives, minor cannabinoids or a custom formulation, the first goal is always the same: a safer, clearer and better-documented product decision.

To support customers properly, our team combines commercial guidance with technical knowledge. Depending on the project, you can work with a Technical Sales Representative, formulation support and product specialists who understand purity, certificates of analysis, legal sensitivity, stability, packaging and the difference between consumer-friendly claims and responsible cannabinoid education.

What We Do

We supply cannabinoid ingredients and cannabinoid-based product solutions for companies that want dependable sourcing and a professional partner rather than a simple catalogue transaction. Our range includes isolated cannabinoids, distillates, oils, water-soluble cannabinoid formats, cosmetic ingredients and white label options for brands that need a faster route to market.

Because cannabinoid products are not all used in the same way, we help customers think through the whole chain: intended product type, cannabinoid profile, quality documentation, local market requirements, packaging expectations, testing needs and consumer education. This matters because a strong cannabinoid product is not only defined by the molecule inside it. It is defined by purity, traceability, stability, communication and the trust users can place in the brand behind it.

We also support international supply challenges where cannabinoid rules, customs expectations and documentation requirements can be complex. Our role is to make the process more predictable and to help customers avoid avoidable mistakes before production, launch or import.

How We Work With Customers

A strong cannabinoid project starts with the right questions. Which market will the product enter? Is the product a raw ingredient, finished consumer product, cosmetic, vape, oil, edible, research material or B2B formulation? Which cannabinoid profile is required? What purity level, documentation and lab testing are needed? Is the project intended for a broad consumer audience, a specialist retail channel or a regulated business environment?

From there, we help customers compare available options and choose a practical path. For some customers that means sourcing a specific cannabinoid ingredient. For others it means exploring CBD oils, pure cannabinoids, terpenes, CPNP services or third-party lab testing. The purpose is not to push every project into the same format, but to match the product idea with the safest and most commercially sensible execution.

Quality, Documentation and Responsibility

Cannabinoid markets move quickly, but speed should never replace quality control. We believe customers should be able to review relevant documentation, understand what they are buying and communicate about cannabinoids without exaggerating health claims. Certificates of analysis, transparent specifications and clear product information are essential for professional buyers and for end users who want to make informed choices.

We follow this same principle in our educational content. Cannabinoids are biologically active compounds and should be explained with care. External scientific resources such as the National Academies review on cannabis and cannabinoids are useful context, but they do not replace product-specific legal, medical or regulatory advice. For that reason, our guidance is designed to support responsible commercial decisions, not to make unsupported treatment promises.